Skip to content

Many HIV-positive children in UK and Ireland receiving too low doses of anti-HIV drugs

Underestimating necessity for HAART, and concerns about side-effects, leads to low uptake and poor adherence

Current, not nadir CD4 cell count predicts risk of lymphoma in HAART era

Mothers able to treat both themselves and new born with nevirapine, says Ugandan study

LGV spreading throughout UK; gay HIV-positive men most affected

Once-daily Kaletra approved for treatment-naive patients in USA (corrected)

News feature: Malaria treatment and HIV: co-artemether is needed, but supply and cost remain as barriers

Risk factors for cardiovascular disease increased in HIV-positive women

Not all microsporidiosis causes chronic diarrhoea according to study from Peru

Nelfinavir and nevirapine well tolerated during pregnancy

HIV in Labour's third term

Hepatitis C can worsen cognitive deficits caused by HIV infection and methamphetamine abuse

BMI, not HIV status or HAART use, associated with diabetes risk in US women's study

Self-prescribed cannabis widely used to treat HIV-related symptoms

Case of Fanconi syndrome caused by ddI reported

Can corticosteroids delay the initiation of HAART?

Treating HIV-positive children with antiretrovirals in first two months increases AIDS free survival

Could wasting on suppressive HAART be a result of cytokines produced by residual HIV replication in sanctuary sites?